TC BIOPHARM LIMITED
Company number SC453579 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£200,092
Balance sheet as at 2016-07-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2013-07-01
- Registered office
- C/O ALVAREZ & MARSAL EUROPE LLP, Sunderland House 149 St Vincent Street, Glasgow, G2 5NW
- Postcode
- G2 5NW
- Capital
- 1 GBP
- Accounts category
- Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-07-01
- Next due by
- 2026-07-15
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 13 resigned
Bryan Leland KOBEL
Director
MR Martin THORP
Director
Group structure
Controlled by TC BIOPHARM (HOLDINGS) PLC — since 2021-12-17
From persons-with-significant-control filings on the public register.
Contact details
- Website
- tcbiopharm.com
TC BioPharm (Nasdaq: TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer.
Previous registered addresses 2
| Address | Changed on |
|---|---|
| PENTLANDS SCIENCE PARK BUSH LOAN, PENICUIK, MIDLOTHIAN, EH26 0PZ | 2015-12-16 |
| 53 MILTON CRESCENT, EDINBURGH, MIDLOTHIAN, EH15 3PQ, SCOTLAND | 2014-06-04 |
The class of 2013
32%
of the 312 companies in this sector incorporated in 2013 are still active today; 63% have since been dissolved.
A fact about the year, not a forecast for this company.